HYBRID SHADOW ADJUDICATION Trademark
Trademark Overview
On Monday, November 3, 2025, a trademark application was filed for HYBRID SHADOW ADJUDICATION with the United States Patent and Trademark Office. The USPTO has given the HYBRID SHADOW ADJUDICATION trademark a serial number of 99476483. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 1, 2026. This trademark is owned by Prime Therapeutics LLC. The HYBRID SHADOW ADJUDICATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Platform as a Service (PAAS) featuring computer software platforms for providing comparisons of data and information from legacy software systems to new software systems to assist in data migration, data integration, business implementations, data configuration, and to identify and resolve issues to minimize post-implementation disruptions in the field of medical clinical trials, medical and prescription drug benefits, utilization and coverage
General Information
| Serial Number | 99476483 |
| Word Mark | HYBRID SHADOW ADJUDICATION |
| Filing Date | Monday, November 3, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, April 1, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 21, 2026 |
Trademark Statements
| Goods and Services | Platform as a Service (PAAS) featuring computer software platforms for providing comparisons of data and information from legacy software systems to new software systems to assist in data migration, data integration, business implementations, data configuration, and to identify and resolve issues to minimize post-implementation disruptions in the field of medical clinical trials, medical and prescription drug benefits, utilization and coverage |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 3, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Prime Therapeutics LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Eagan, MN 55121
US |
Trademark Events
| Event Date | Event Description |
| Monday, November 3, 2025 | NEW APPLICATION ENTERED |
| Monday, November 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, March 17, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, March 18, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 18, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 18, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 25, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 25, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 25, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 25, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 25, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
